No headlines found.
Successful Pilot Scale Run with Cayman Chemical Validates eXoZymes' Technology and Scalability
ACCESS Newswire (Wed, 18-Mar 9:10 AM ET)
eXoZymes' CCO Damien Perriman to Present a NCT Solution at Next Week's MISTA Symposium
ACCESS Newswire (Thu, 12-Mar 4:15 PM ET)
ACCESS Newswire (Tue, 10-Feb 4:20 PM ET)
eXoZymes Advancing Commercial Readiness With Profound Production Metrics on Initial NCT Pilot Run
ACCESS Newswire (Thu, 29-Jan 7:45 PM ET)
EXoZymes Inc is focused on using a biomanufacturing platform to create valuable biochemicals, including Active Pharmaceutical Ingredients or APIs, biofuels, food flavors, and cosmetics, offering a sustainable alternative to traditional chemical production methods.
Exozymes trades on the NASDAQ stock market under the symbol EXOZ.
As of March 24, 2026, EXOZ stock price declined to $7.25 with 2,682 million shares trading.
EXOZ has a market cap of $60.90 million. This is considered a Micro Cap stock.
The top ETF exchange traded funds that EXOZ belongs to (by Net Assets): VXF, IWC, VTI.
EXOZ has underperformed the market in the last year with a return of -44.7%, while the SPY ETF gained +15.1%. In the last 3 month period, EXOZ fell short of the market, returning -41.9%, while SPY returned -5.1%. However, in the most recent 2 weeks EXOZ has outperformed the stock market by returning -0.7%, while SPY returned -3.3%.
EXOZ support price is $6.95 and resistance is $7.81 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EXOZ shares will trade within this expected range on the day.